Published in Int J Radiat Oncol Biol Phys on September 01, 1989
Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy. Phys Med Biol (2008) 1.20
Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc (2002) 1.01
Proton radiobiology. Cancers (Basel) (2015) 0.89
Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? Curr Oncol (2014) 0.80
Proton therapy for uveal melanomas and other eye lesions. Strahlenther Onkol (1999) 0.80
The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review. Strahlenther Onkol (2009) 0.76
Preliminary results of proton radiotherapy for choroidal melanoma - the Kraków experience. Contemp Oncol (Pozn) (2014) 0.75
The biology of uveal melanoma. Cancer Metastasis Rev (2017) 0.75
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.96
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.92
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science (1997) 6.00
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA (1994) 5.43
Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science (2001) 5.16
Current treatment of metastatic choroidal tumors. Oncology (Williston Park) (1989) 5.15
A prospective study of cigarette smoking and risk of cataract in men. JAMA (1992) 3.72
The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. N Engl J Med (1989) 3.63
The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med (1989) 3.11
Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Med Care (1992) 3.06
Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys (1995) 3.05
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95
A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA (1992) 2.87
Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85
Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2000) 2.68
Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology (1998) 2.62
The spectrum and burden of ocular injury. Ophthalmology (1988) 2.54
Ocular blood flow velocity in age-related macular degeneration. Ophthalmology (1995) 2.53
X-ray diffraction study of the polymorphism of hydrated diacyl- and dialkylphosphatidylethanolamines. Biochemistry (1984) 2.45
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology (1996) 2.41
A pencil beam algorithm for proton dose calculations. Phys Med Biol (1996) 2.39
Calorimetric studies of the gel-fluid (L beta-L alpha) and lamellar-inverted hexagonal (L alpha-HII) phase transitions in dialkyl- and diacylphosphatidylethanolamines. Biochemistry (1983) 2.33
Adverse reactions due to indocyanine green. Ophthalmology (1994) 2.30
Fatal toxicity of drugs used in the treatment of psychotic illnesses. Br J Psychiatry (1998) 2.14
Trends in childhood disability. Am J Public Health (1984) 2.03
Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol (1999) 1.98
A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr (1999) 1.95
Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol (1994) 1.93
A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr (1999) 1.90
Retinal manifestations of neurofibromatosis. Diagnosis and management. Arch Ophthalmol (1991) 1.88
Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol (1999) 1.86
Compensating for heterogeneities in proton radiation therapy. Phys Med Biol (1984) 1.86
Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology (1989) 1.82
Survival of patients with metastases from uveal melanoma. Ophthalmology (1991) 1.80
Falls in elderly patients with glaucoma. Arch Ophthalmol (1991) 1.74
The incidence of eye injuries in New England adults. Arch Ophthalmol (1988) 1.71
Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels. J Urol (1991) 1.69
Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry (1986) 1.68
A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol (1983) 1.67
Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr (2001) 1.64
Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol (1996) 1.64
Clinical course of macular holes: the Eye Disease Case-Control Study. Arch Ophthalmol (1999) 1.64
Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am (1998) 1.63
Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol (1990) 1.62
Dose-volume histograms. Int J Radiat Oncol Biol Phys (1991) 1.62
Monochromatic ophthalmoscopy and fundus photography. The normal fundus. Arch Ophthalmol (1977) 1.58
Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol (1987) 1.57
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol (2000) 1.53
Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology (1980) 1.53
Dose conformity of gamma knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys (2001) 1.52
Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst (2000) 1.51
Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration. Br J Ophthalmol (2008) 1.49
Registered Replication Report: Schooler and Engstler-Schooler (1990). Perspect Psychol Sci (2014) 1.48
Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest Ophthalmol Vis Sci (1990) 1.48
Development of an Australian drug utilisation database: a report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee. Pharmacoeconomics (1993) 1.45
Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol (1992) 1.45
Distribution of indicator bacteria and Vibrio parahaemolyticus in sewage-polluted intertidal sediments. Appl Environ Microbiol (1987) 1.44
Nutrient intake and cataract extraction in women: a prospective study. BMJ (1992) 1.44
Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci (2000) 1.43
Gamma knife radiosurgery in children. Pediatr Neurosurg (1996) 1.43
Metastability and polymorphism in the gel and fluid bilayer phases of dilauroylphosphatidylethanolamine. Two crystalline forms in excess water. J Biol Chem (1983) 1.43
Recent changes in the profile of prescription NSAID use in Australia. Med J Aust (2000) 1.41
Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology (1992) 1.39
Long-term results of proton beam irradiated uveal melanomas. Ophthalmology (1987) 1.37
A cost-effectiveness approach to drug subsidy and pricing in Australia. Health Aff (Millwood) (2001) 1.37
MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys (2001) 1.35
Profile of cognitive progression in early Huntington's disease. Neurology (2003) 1.35
Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology (1997) 1.33
Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden. Eur J Clin Pharmacol (1997) 1.33
Activation of cAMP-dependent protein kinase A in prefrontal cortex impairs working memory performance. J Neurosci (1999) 1.33
Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet (1999) 1.33
Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina (1988) 1.33
Clinical experience with jet insulin injection in diabetes mellitus therapy: a clue to the pathogenesis of lipodystrophy. Ala J Med Sci (1974) 1.31
Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol (2002) 1.30
Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol (2001) 1.27
Disciform degeneration of the macula. II. Pathogenesis. Arch Ophthalmol (1976) 1.26
Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology (1987) 1.26
Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology (1996) 1.25
Proton radiation as boost therapy for localized prostatic carcinoma. JAMA (1979) 1.25
Vitamins, minerals, and macular degeneration. Promising but unproven hypotheses. Arch Ophthalmol (1994) 1.25
Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol (1995) 1.24
Natural history of disciform degeneration of the macula. Am J Ophthalmol (1974) 1.20
Degradation of the Bragg peak due to inhomogeneities. Phys Med Biol (1986) 1.19
Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.18
Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys (2000) 1.18
Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol (1985) 1.17
Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit Rev Toxicol (2006) 1.17
An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage. Biochemistry (1986) 1.16